| Concurrent Chemoradiotherapy Combined With Adjuvant Chemotherapy Treated Advanced Cervical Cancer (NCT05735145) | Fourth Affiliated Hospital of Guangxi Medical University | 2022-07-01 |
| Evaluation the Effects of Herbal Gargle for Chemoradiotherapy-induced Oral Mucositis of Head & Neck Cancer, a Pilot Study. (NCT05341206) | Chang Gung Memorial Hospital | 2022-04-15 |
| PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer (NCT05311566) | Lei Li | 2022-03-27 |
| Chemoradiotherapy Sequenced Radical Surgery for Colorectal Cancer With PALNM (NCT05129774) | Qilu Hospital of Shandong University | 2022-01-01 |
| Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer (NCT05161572) | Fudan University | 2021-09-28 |
| Concurrent Radiochemotherapy Plus Anlotinib for Locally Advanced Cervical Cancer (NCT04772001) | Zhongnan Hospital | 2021-03-12 |
| Compliance to Cervical Cancer Chemoradiation Guidelines: A Multicentric Implementation Audit and Resource Assessment Initiative of National Cancer Grid of India (NCT07290972) | Tata Memorial Hospital | 2021-02-01 |
| Nutritional Status and Clinical Outcomes in Patients With Common Malignancies(NCOM) (NCT06219083) | Xiaoqin Luo | 2020-11-12 |
| Prospective Evaluation of Immunological, Molecular-genetic, Image-based and Microbial Analyzes to Characterize Tumor Response and Control in Patients With Inoperable Stage III NSCLC Treated With Chemoradiotherapy Followed by Consolidation Therapy With Durvalumab (NCT05027165) | LMU Klinikum | 2020-11-07 |
| Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17) (NCT04764227) | Fudan University | 2020-05-30 |
| Multi Dimensional Precise Exploration of Immunoconsolidation Therapy for Locally Advanced NSCLC After Chemo-radiotherapy (NCT04741633) | Fudan University | 2020-04-01 |
| To Compare the Effect of Different Nutritional Pathways on Improving Nutritional Status of Esophageal Cancer Patients Undergoing Chemoradiotherapy (NCT04199832) | Tianjin Medical University Cancer Institute and Hospital | 2019-12-20 |
| Study on Predictive Biomarkers of Neoadjuvant Chemoradiotherapy for Rectal Cancer (NCT04227886) | Fudan University | 2019-12-01 |
| A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer (NCT04207918) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2019-11-14 |
| Chemoradiotherapy in Unresectable Esophageal Cancer (NCT04278287) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2019-10-01 |
| Toripalimab With Preoperative Chemoradiotherapy for LA-EGJ (NCT04061928) | Peking University | 2019-08-26 |
| PD-1 Inhibitors Plus Chemoradiotherapy for Metastatic Nasopharyngeal Carcinoma: an Open-label Single-arm, Phase II Trial (NCT05520814) | Sichuan Cancer Hospital and Research Institute | 2018-08-01 |
| A Pilot Study of Additional Chinese Formula for Concurrent Chemoradiotherapy in Oral Cavity Cancer Patients (NCT05590650) | China Medical University Hospital | 2018-07-07 |
| Non-OpeRative MANagement of Rectal Cancer Patients (NCT04696757) | Kangbuk Samsung Hospital | 2018-02-01 |
| Analysis of Nutrition During Chemoradiotherapy in Patients With Gastrointestinal Cancer (NCT03286348) | Fudan University | 2017-09-01 |
| Total Neoadjuvant Treatment vs. Chemoradiotherapy in Local Advanced Rectal Cancer With High Risk Factors (NCT03177382) | West China Hospital | 2017-06-15 |
| A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma (NCT02301481) | Chinese Academy of Medical Sciences | 2014-01-01 |
| Upfront Bevacizumab/témozolomide for Gliomastomas With Neurological Impairment (NCT03623347) | Centre Hospitalier Universitaire, Amiens | 2011-01-01 |
| A Study for Short Preoperative Chemoradiotherapy for Resectable Rectal Carcinoma (NCT00973778) | Shanghai Jiao Tong University School of Medicine | 2009-07-01 |